世界の遺伝子欠失ワクチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gene-Deleted Vaccines Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4249 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、遺伝子欠失ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単一遺伝子削除ワクチン、二重遺伝子削除ワクチン）、用途別市場規模（獣医病院、獣医クリニック、動物ケアセンター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遺伝子欠失ワクチンの市場動向 ・企業の競争状況、市場シェア ・遺伝子欠失ワクチンの種類別市場規模と予測2016-2027（単一遺伝子削除ワクチン、二重遺伝子削除ワクチン） ・遺伝子欠失ワクチンの用途別市場規模と予測2016-2027（獣医病院、獣医クリニック、動物ケアセンター、その他） ・遺伝子欠失ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・遺伝子欠失ワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝子欠失ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝子欠失ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝子欠失ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Virbac SA、Merck Animal Health、Zoetis Inc、Boehringer Ingelheim GmbH、Ceva、Bayer、Biogenesis-Bago、Indian Immunologicals Ltd、Heska Corporation） ・結論

A Gene Deletion Vaccine is a vaccine developed without the ability to replicate by deleting important genes.These substances are very harmless because they cannot be released into the environment.Another benefit of live vaccines is that they can often be delivered via the mucosal route, which is a natural route of infection, thereby inducing mucosal immunity through systemic immunity.By increasing mucosal immunity, disease progression can be halted at the onset of infection.

Market Analysis and Insights: Global Gene-Deleted Vaccines Market
The global Gene-Deleted Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene-Deleted Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene-Deleted Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene-Deleted Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene-Deleted Vaccines market.

Global Gene-Deleted Vaccines Scope and Market Size
Gene-Deleted Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene-Deleted Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Single Gene Deleted Vaccine
Double Gene Deleted Vaccine

Segment by Application
Veterinary Hospitals
Veterinary Clinics
Animal Care Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Virbac SA
Merck Animal Health
Zoetis Inc
Boehringer Ingelheim GmbH
Ceva
Bayer
Biogenesis-Bago
Indian Immunologicals Ltd
Heska Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene-Deleted Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Single Gene Deleted Vaccine
1.2.3 Double Gene Deleted Vaccine
1.3 Market by Application
1.3.1 Global Gene-Deleted Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Animal Care Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene-Deleted Vaccines Market Perspective (2016-2027)
2.2 Gene-Deleted Vaccines Growth Trends by Regions
2.2.1 Gene-Deleted Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene-Deleted Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Gene-Deleted Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Gene-Deleted Vaccines Industry Dynamic
2.3.1 Gene-Deleted Vaccines Market Trends
2.3.2 Gene-Deleted Vaccines Market Drivers
2.3.3 Gene-Deleted Vaccines Market Challenges
2.3.4 Gene-Deleted Vaccines Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene-Deleted Vaccines Players by Revenue
3.1.1 Global Top Gene-Deleted Vaccines Players by Revenue (2016-2021)
3.1.2 Global Gene-Deleted Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Gene-Deleted Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene-Deleted Vaccines Revenue
3.4 Global Gene-Deleted Vaccines Market Concentration Ratio
3.4.1 Global Gene-Deleted Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene-Deleted Vaccines Revenue in 2020
3.5 Gene-Deleted Vaccines Key Players Head office and Area Served
3.6 Key Players Gene-Deleted Vaccines Product Solution and Service
3.7 Date of Enter into Gene-Deleted Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene-Deleted Vaccines Breakdown Data by Type
4.1 Global Gene-Deleted Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Gene-Deleted Vaccines Forecasted Market Size by Type (2022-2027)

5 Gene-Deleted Vaccines Breakdown Data by Application
5.1 Global Gene-Deleted Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Gene-Deleted Vaccines Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene-Deleted Vaccines Market Size (2016-2027)
6.2 North America Gene-Deleted Vaccines Market Size by Type
6.2.1 North America Gene-Deleted Vaccines Market Size by Type (2016-2021)
6.2.2 North America Gene-Deleted Vaccines Market Size by Type (2022-2027)
6.2.3 North America Gene-Deleted Vaccines Market Size by Type (2016-2027)
6.3 North America Gene-Deleted Vaccines Market Size by Application
6.3.1 North America Gene-Deleted Vaccines Market Size by Application (2016-2021)
6.3.2 North America Gene-Deleted Vaccines Market Size by Application (2022-2027)
6.3.3 North America Gene-Deleted Vaccines Market Size by Application (2016-2027)
6.4 North America Gene-Deleted Vaccines Market Size by Country
6.4.1 North America Gene-Deleted Vaccines Market Size by Country (2016-2021)
6.4.2 North America Gene-Deleted Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gene-Deleted Vaccines Market Size (2016-2027)
7.2 Europe Gene-Deleted Vaccines Market Size by Type
7.2.1 Europe Gene-Deleted Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Gene-Deleted Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Gene-Deleted Vaccines Market Size by Type (2016-2027)
7.3 Europe Gene-Deleted Vaccines Market Size by Application
7.3.1 Europe Gene-Deleted Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Gene-Deleted Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Gene-Deleted Vaccines Market Size by Application (2016-2027)
7.4 Europe Gene-Deleted Vaccines Market Size by Country
7.4.1 Europe Gene-Deleted Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Gene-Deleted Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene-Deleted Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Gene-Deleted Vaccines Market Size by Type
8.2.1 Asia-Pacific Gene-Deleted Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene-Deleted Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene-Deleted Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene-Deleted Vaccines Market Size by Application
8.3.1 Asia-Pacific Gene-Deleted Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene-Deleted Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene-Deleted Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene-Deleted Vaccines Market Size by Region
8.4.1 Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene-Deleted Vaccines Market Size (2016-2027)
9.2 Latin America Gene-Deleted Vaccines Market Size by Type
9.2.1 Latin America Gene-Deleted Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Gene-Deleted Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Gene-Deleted Vaccines Market Size by Type (2016-2027)
9.3 Latin America Gene-Deleted Vaccines Market Size by Application
9.3.1 Latin America Gene-Deleted Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Gene-Deleted Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Gene-Deleted Vaccines Market Size by Application (2016-2027)
9.4 Latin America Gene-Deleted Vaccines Market Size by Country
9.4.1 Latin America Gene-Deleted Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Gene-Deleted Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene-Deleted Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Gene-Deleted Vaccines Market Size by Type
10.2.1 Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene-Deleted Vaccines Market Size by Application
10.3.1 Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene-Deleted Vaccines Market Size by Country
10.4.1 Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Virbac SA
11.1.1 Virbac SA Company Details
11.1.2 Virbac SA Business Overview
11.1.3 Virbac SA Gene-Deleted Vaccines Introduction
11.1.4 Virbac SA Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.1.5 Virbac SA Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Details
11.2.2 Merck Animal Health Business Overview
11.2.3 Merck Animal Health Gene-Deleted Vaccines Introduction
11.2.4 Merck Animal Health Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.2.5 Merck Animal Health Recent Development
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Details
11.3.2 Zoetis Inc Business Overview
11.3.3 Zoetis Inc Gene-Deleted Vaccines Introduction
11.3.4 Zoetis Inc Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.3.5 Zoetis Inc Recent Development
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Details
11.4.2 Boehringer Ingelheim GmbH Business Overview
11.4.3 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Introduction
11.4.4 Boehringer Ingelheim GmbH Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.4.5 Boehringer Ingelheim GmbH Recent Development
11.5 Ceva
11.5.1 Ceva Company Details
11.5.2 Ceva Business Overview
11.5.3 Ceva Gene-Deleted Vaccines Introduction
11.5.4 Ceva Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.5.5 Ceva Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Gene-Deleted Vaccines Introduction
11.6.4 Bayer Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Biogenesis-Bago
11.7.1 Biogenesis-Bago Company Details
11.7.2 Biogenesis-Bago Business Overview
11.7.3 Biogenesis-Bago Gene-Deleted Vaccines Introduction
11.7.4 Biogenesis-Bago Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.7.5 Biogenesis-Bago Recent Development
11.8 Indian Immunologicals Ltd
11.8.1 Indian Immunologicals Ltd Company Details
11.8.2 Indian Immunologicals Ltd Business Overview
11.8.3 Indian Immunologicals Ltd Gene-Deleted Vaccines Introduction
11.8.4 Indian Immunologicals Ltd Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.8.5 Indian Immunologicals Ltd Recent Development
11.9 Heska Corporation
11.9.1 Heska Corporation Company Details
11.9.2 Heska Corporation Business Overview
11.9.3 Heska Corporation Gene-Deleted Vaccines Introduction
11.9.4 Heska Corporation Revenue in Gene-Deleted Vaccines Business (2016-2021)
11.9.5 Heska Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene-Deleted Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Single Gene Deleted Vaccine
Table 3. Key Players of Double Gene Deleted Vaccine
Table 4. Global Gene-Deleted Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gene-Deleted Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene-Deleted Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gene-Deleted Vaccines Market Share by Regions (2016-2021)
Table 8. Global Gene-Deleted Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gene-Deleted Vaccines Market Share by Regions (2022-2027)
Table 10. Gene-Deleted Vaccines Market Trends
Table 11. Gene-Deleted Vaccines Market Drivers
Table 12. Gene-Deleted Vaccines Market Challenges
Table 13. Gene-Deleted Vaccines Market Restraints
Table 14. Global Gene-Deleted Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gene-Deleted Vaccines Market Share by Players (2016-2021)
Table 16. Global Top Gene-Deleted Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene-Deleted Vaccines as of 2020)
Table 17. Ranking of Global Top Gene-Deleted Vaccines Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gene-Deleted Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene-Deleted Vaccines Product Solution and Service
Table 21. Date of Enter into Gene-Deleted Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene-Deleted Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gene-Deleted Vaccines Revenue Market Share by Type (2016-2021)
Table 25. Global Gene-Deleted Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gene-Deleted Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gene-Deleted Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gene-Deleted Vaccines Revenue Market Share by Application (2016-2021)
Table 29. Global Gene-Deleted Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gene-Deleted Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gene-Deleted Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gene-Deleted Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gene-Deleted Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gene-Deleted Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gene-Deleted Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gene-Deleted Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gene-Deleted Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gene-Deleted Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gene-Deleted Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gene-Deleted Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gene-Deleted Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gene-Deleted Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gene-Deleted Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gene-Deleted Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gene-Deleted Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gene-Deleted Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gene-Deleted Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gene-Deleted Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gene-Deleted Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gene-Deleted Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gene-Deleted Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gene-Deleted Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Virbac SA Company Details
Table 62. Virbac SA Business Overview
Table 63. Virbac SA Gene-Deleted Vaccines Product
Table 64. Virbac SA Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 65. Virbac SA Recent Development
Table 66. Merck Animal Health Company Details
Table 67. Merck Animal Health Business Overview
Table 68. Merck Animal Health Gene-Deleted Vaccines Product
Table 69. Merck Animal Health Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 70. Merck Animal Health Recent Development
Table 71. Zoetis Inc Company Details
Table 72. Zoetis Inc Business Overview
Table 73. Zoetis Inc Gene-Deleted Vaccines Product
Table 74. Zoetis Inc Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 75. Zoetis Inc Recent Development
Table 76. Boehringer Ingelheim GmbH Company Details
Table 77. Boehringer Ingelheim GmbH Business Overview
Table 78. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product
Table 79. Boehringer Ingelheim GmbH Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 80. Boehringer Ingelheim GmbH Recent Development
Table 81. Ceva Company Details
Table 82. Ceva Business Overview
Table 83. Ceva Gene-Deleted Vaccines Product
Table 84. Ceva Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 85. Ceva Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Gene-Deleted Vaccines Product
Table 89. Bayer Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Biogenesis-Bago Company Details
Table 92. Biogenesis-Bago Business Overview
Table 93. Biogenesis-Bago Gene-Deleted Vaccines Product
Table 94. Biogenesis-Bago Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 95. Biogenesis-Bago Recent Development
Table 96. Indian Immunologicals Ltd Company Details
Table 97. Indian Immunologicals Ltd Business Overview
Table 98. Indian Immunologicals Ltd Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 99. Indian Immunologicals Ltd Recent Development
Table 100. Heska Corporation Company Details
Table 101. Heska Corporation Business Overview
Table 102. Heska Corporation Gene-Deleted Vaccines Product
Table 103. Heska Corporation Revenue in Gene-Deleted Vaccines Business (2016-2021) & (US$ Million)
Table 104. Heska Corporation Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene-Deleted Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Single Gene Deleted Vaccine Features
Figure 3. Double Gene Deleted Vaccine Features
Figure 4. Global Gene-Deleted Vaccines Market Share by Application: 2020 VS 2027
Figure 5. Veterinary Hospitals Case Studies
Figure 6. Veterinary Clinics Case Studies
Figure 7. Animal Care Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Gene-Deleted Vaccines Report Years Considered
Figure 10. Global Gene-Deleted Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gene-Deleted Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gene-Deleted Vaccines Market Share by Regions: 2020 VS 2027
Figure 13. Global Gene-Deleted Vaccines Market Share by Regions (2022-2027)
Figure 14. Global Gene-Deleted Vaccines Market Share by Players in 2020
Figure 15. Global Top Gene-Deleted Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene-Deleted Vaccines as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gene-Deleted Vaccines Revenue in 2020
Figure 17. Global Gene-Deleted Vaccines Revenue Market Share by Type (2016-2021)
Figure 18. Global Gene-Deleted Vaccines Revenue Market Share by Type (2022-2027)
Figure 19. North America Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gene-Deleted Vaccines Market Share by Type (2016-2027)
Figure 21. North America Gene-Deleted Vaccines Market Share by Application (2016-2027)
Figure 22. North America Gene-Deleted Vaccines Market Share by Country (2016-2027)
Figure 23. United States Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene-Deleted Vaccines Market Share by Type (2016-2027)
Figure 27. Europe Gene-Deleted Vaccines Market Share by Application (2016-2027)
Figure 28. Europe Gene-Deleted Vaccines Market Share by Country (2016-2027)
Figure 29. Germany Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene-Deleted Vaccines Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gene-Deleted Vaccines Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gene-Deleted Vaccines Market Share by Region (2016-2027)
Figure 39. China Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene-Deleted Vaccines Market Share by Type (2016-2027)
Figure 47. Latin America Gene-Deleted Vaccines Market Share by Application (2016-2027)
Figure 48. Latin America Gene-Deleted Vaccines Market Share by Country (2016-2027)
Figure 49. Mexico Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene-Deleted Vaccines Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gene-Deleted Vaccines Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gene-Deleted Vaccines Market Share by Country (2016-2027)
Figure 55. Turkey Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gene-Deleted Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Virbac SA Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 59. Merck Animal Health Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 60. Zoetis Inc Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 61. Boehringer Ingelheim GmbH Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 62. Ceva Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 64. Biogenesis-Bago Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 65. Indian Immunologicals Ltd Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 66. Heska Corporation Revenue Growth Rate in Gene-Deleted Vaccines Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---